Lummis Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.28M Sell
12,849
-24
-0.2% -$5.59K 1.96% 15
2026
Q1
$3.04M Sell
12,873
-500
-4% -$116K 1.82% 17
2025
Q4
$2.77M Sell
13,373
-211
-2% -$41.7K 1.7% 21
2025
Q3
$2.52M Sell
13,584
-14
-0.1% -$2.4K 1.65% 21
2025
Q2
$2.23M Sell
13,598
-145
-1% -$22.3K 1.46% 22
2025
Q1
$2.21M Buy
13,743
+7,490
+120% +$1.17M 1.53% 23
2024
Q4
$904K Sell
6,253
-2
-0% -$310 1.15% 25
2024
Q3
$1.01M Hold
6,255
1.18% 24
2024
Q2
$914K Sell
6,255
-35
-0.6% -$5.21K 1.21% 25
2024
Q1
$995K Sell
6,290
-7,568
-55% -$1.2M 1.33% 24
2023
Q4
$2.17M Buy
+13,858
New +$2.12M 1.66% 17

Other funds holding JNJ

Lummis Asset Management's JNJ Position: Q2 2026 in Review

Lummis Asset Management reduced its Johnson & Johnson (JNJ) stake by 0.19% in Q2 2026, selling an estimated $5.59K and leaving 12,849 shares worth $3.28M. The position accounts for 1.96% of the portfolio, ranked #15.

Lummis Asset Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lummis Asset Management held 12,849 shares of Johnson & Johnson worth $3.28M as of Q2 2026.
  • Lummis Asset Management sold 24 Johnson & Johnson shares in Q2 2026, an estimated $5.59K.
  • Johnson & Johnson made up 1.96% of Lummis Asset Management's portfolio in Q2 2026, its #15 holding.
  • Lummis Asset Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lummis Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.